Workflow
HJHS(603616)
icon
Search documents
韩建河山涨2.17%,成交额2065.02万元,主力资金净流出165.30万元
Xin Lang Cai Jing· 2025-12-18 02:42
Group 1 - The stock price of Han Jian He Shan increased by 2.17% to 5.17 CNY per share, with a total market capitalization of 2.023 billion CNY as of December 18 [1] - The company has seen a year-to-date stock price increase of 47.29%, but has experienced a decline of 0.77% over the last five trading days and 12.52% over the last 20 days [1] - Han Jian He Shan has appeared on the "Dragon and Tiger List" 13 times this year, with the most recent appearance on November 5, where it recorded a net buy of -33.44 million CNY [1] Group 2 - Han Jian He Shan operates in the building materials sector, specifically in cement and cement products, and is involved in various concepts such as micro-market stocks and PPP [2] - As of September 30, the number of shareholders decreased by 11.65% to 39,400, while the average circulating shares per person increased by 14.05% to 9,757 shares [2] - For the period from January to September 2025, the company achieved a revenue of 548 million CNY, representing a year-on-year growth of 37.39%, and a net profit of 9.76 million CNY, up 123.72% year-on-year [2] Group 3 - Since its A-share listing, Han Jian He Shan has distributed a total of 24.62 million CNY in dividends, with no dividends paid in the last three years [3]
韩建河山:二级市场股价波动受多种因素影响
Zheng Quan Ri Bao· 2025-12-17 14:15
证券日报网讯 12月17日,韩建河山在互动平台回答投资者提问时表示,二级市场股价波动受多种因素 影响,公司管理层始终专注于提升公司经营业绩,致力于以良好的业绩回报公司股东。 (文章来源:证券日报) ...
韩建河山:控股股东质押风险在可控范围之内
Zheng Quan Ri Bao Wang· 2025-12-17 13:44
证券日报网讯12月17日,韩建河山(603616)在互动平台回答投资者提问时表示,公司控股股东股份质 押情况已按相关规定履行了信息披露义务,截至目前控股股东质押风险在可控范围之内。公司将持续关 注质押情况,并依法履行信息披露义务。 ...
3.2亿买,0元卖! 韩建河山高溢价并购踩雷遭问询,公司回复
Core Viewpoint - The company, Han Jian He Shan, is under scrutiny for its acquisition of Qingqing Environmental Protection, which was made at a significantly high premium, raising questions about the prudence of the decision given the subsequent poor performance of the acquired entity [1][2]. Group 1: Acquisition Details - The acquisition of Qingqing Environmental Protection was completed in 2018 for 320 million yuan, representing a premium of 1833.38% over its valuation [1]. - The company claims the acquisition was driven by diversification needs and favorable policies in the environmental sector, with the transaction price being lower than the assessed value of 326 million yuan [2]. Group 2: Performance and Financial Issues - Qingqing Environmental Protection was expected to achieve a net profit of no less than 120 million yuan during the performance commitment period but only managed to report 123 million yuan, which was later adjusted down to 106 million yuan due to accounting errors [1]. - As of the end of 2024, Qingqing Environmental Protection has 115 million yuan in accounts receivable that are over four years old, with 81.23 million yuan of this amount remaining uncollected [1][2]. Group 3: Response to Regulatory Concerns - The company attributes the poor performance of Qingqing Environmental Protection from 2022 to 2024 to the completion of ultra-low emissions transformation in the steel industry, economic downturn, and increased competition [2]. - The company has taken measures to recover the outstanding accounts receivable, which it claims are primarily due to clients facing financial difficulties [2].
北京韩建河山管业股份有限公司关于资产出售事项的监管工作函的回复公告
Core Viewpoint - The company, Beijing Hanjian Heshan Pipeline Co., Ltd., is responding to a regulatory inquiry regarding the sale of its subsidiary, Qingqing Environmental Protection Equipment Co., Ltd., for 0 yuan, despite having acquired it for 320 million yuan in 2018, resulting in a significant loss of value and raising concerns about the prudence of the acquisition decision [2][4][27]. Group 1: Acquisition and Financial Performance - The company acquired 100% of Qingqing Environmental for 320 million yuan in June 2018, with a valuation increase of 1833.38% [2][4]. - Qingqing Environmental's net asset value was reported at -28.43 million yuan as of the assessment date, with an evaluation value of -20.59 million yuan [2][27]. - The company reported that Qingqing Environmental's actual net profit during the performance commitment period was 1.06 billion yuan, with a commitment fulfillment rate of 102.30% [2][4]. Group 2: Regulatory Concerns and Responses - The regulatory body raised concerns about the prudence of the acquisition decision, given the high premium paid and the subsequent decline in performance post-commitment period [3][4]. - The company emphasized that the acquisition was based on favorable market conditions and a strategic shift towards the environmental sector, which was expected to grow due to increasing pollution control standards [4][5]. - The company has taken measures to address the long-term uncollected receivables from Qingqing Environmental, amounting to 115 million yuan, which were recognized during the performance commitment period [2][17]. Group 3: Market and Industry Analysis - The environmental protection industry is expected to grow significantly, particularly in non-electric sectors, as stricter pollution control policies are implemented [5][10]. - The company identified that the decline in Qingqing Environmental's performance post-2021 was due to reduced demand from steel companies, exacerbated by economic downturns and public health events [10][11]. - The competitive landscape in the environmental sector has intensified, with many new entrants, including state-owned enterprises, leading to increased market pressure [11][12]. Group 4: Future Plans and Debt Management - The company plans to sell 99.9% of Qingqing Environmental to Hebei Qingneng, with a debt waiver of 3.9 million yuan and a repayment plan for the remaining 7.5 million yuan by the end of 2027 [27][33]. - The repayment will occur in three installments, with interest calculated at an annual rate of 1.5% [27][33]. - The company aims to improve Qingqing Environmental's cash flow and operational efficiency post-acquisition by integrating resources and enhancing project management [33].
韩建河山(603616) - 关于北京韩建河山管业股份有限公司资产出售事项的监管工作函的核查回复意见
2025-12-16 10:31
关于北京韩建河山管业股份有限公司 资产出售事项的监管工作函的核查回复意见 上海证券交易所上市公司监管一部: 信永中和会计师事务所(特殊普通合伙)(以下简称"我们"、"会计师")通 过北京韩建河山管业股份有限公司(以下简称"公司"或"韩建河山")收悉贵 所于近日下发的《关于北京韩建河山管业股份有限公司资产出售事项的监管工作 函》(上证公函【2025】4002 号)(以下简称"《监管工作函》")。根据"监管工 作函"的要求,我们就要求会计师核查和发表意见的事项进行了核查,现回复如 下: 问题 2. 关于清青环保 根据公告,公司对清青环保其他应收款余额为1,140.21万元,拟豁免390.21 万元,剩余 750 万元约定于 2027 年 12 月 31 日前偿还完毕。 请公司:(1)列示自收购清青环保以来,按交易性质,公司与清青环保的 往来款项情况及目前余额等;(2)详细说明豁免 390.21 万元债务的形成背景, 豁免的主要考虑及合理性,是否存在其他利益安排;(3)说明公司自收购清青 环保以来对其提供的担保情况,包括但不限于发生时间、担保原因、解除情况 及目前在途担保情况;(4)补充说明剩余 750 万元应收账 ...
韩建河山(603616) - 韩建河山关于资产出售事项的监管工作函的回复公告
2025-12-16 10:31
证券代码:603616 证券简称:韩建河山 公告编号:2025-073 北京韩建河山管业股份有限公司 关于资产出售事项的监管工作函的回复公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏,并对其内容的真实性、准确性和完整性承担法律责任。 1、收购清青环保股权概述 收购清青环保之前,公司业务以 PCCP 生产和销售为主。由于 PCCP 主要应用 于大型调水工程,年市场销量受政府固定资产投资计划影响而具有很强的波动性, 且行业竞争日益激烈,利润空间不断被压缩。为摆脱产品单一、市场波动性强、 竞争日趋激烈等难题,公司积极寻求通过收购进入新的行业领域,实现业务多元 化和转型升级,拓展公司发展空间。从政策环境、行业发展趋势等方面综合研判, 结合公司实际情况,经研究最终确定以环保行业为突破口。选择清青环保作为收 购标的的主要原因如下:(1)大气治理政策标准日益提高。环保部 2017 年 6 月 13 日发布关于征求《钢铁烧结、球团工业大气污染物排放标准》等 20 项国家污 染物排放标准修改单(征求意见稿)意见的函(环办大气函[2017]924 号),修 改钢铁、建材、有色、火电、锅炉、 ...
韩建河山:关于中标项目签订合同的公告
Zheng Quan Ri Bao· 2025-12-09 13:44
证券日报网讯 12月9日晚间,韩建河山发布公告称,公司近日收到了某集团有限公司与公司双方签字盖 章的管材采购合同,签约合同价为387,513,511元人民币,供货期自2026年4月30日至2030年4月29 日。 (文章来源:证券日报) ...
12月9日晚间重要公告一览
Xi Niu Cai Jing· 2025-12-09 10:29
Group 1 - Wanma Technology has been pre-awarded a total of 59.9434 million yuan for multiple State Grid projects, which accounts for 14.49% of its latest audited main business revenue [1] - Tianen Kang's subsidiary received a drug registration certificate for Methimazole tablets, a medication used for hyperthyroidism [2] - Taijing Technology invested 10 million yuan to establish a special fund focused on high-speed network communication chips [3] Group 2 - Youyou Foods plans to use 10 million yuan of its own funds to purchase principal-protected financial products with an expected annual yield of 0.5%-5.0% [4] - Yangfan New Materials announced the release of detention measures against its controlling shareholder, allowing him to resume his duties [5] - Xianju Pharmaceutical received approval for a supplementary application for Nicardipine injection, a calcium channel blocker used for acute hypertension [6] Group 3 - Jingu Co. plans to repurchase shares worth 30-60 million yuan for employee stock ownership plans or equity incentives [7] - Double Tower Foods' Thai subsidiary has completed the construction of its production line and is in the initial production phase [8] - Tongyi Zhong intends to invest approximately 198 million yuan in a project for the industrialization of ultra-high molecular weight polyethylene fibers [9][10] Group 4 - Zhangyue Technology received a dividend of 4.99 million yuan from its stake in Dianzhong Technology, which represents 10.12% of its audited net profit for 2024 [11] - Sihua Electronics announced the resignation of its general manager due to job transfer, with the current manager continuing until a new one is appointed [12] - Jiutian Pharmaceutical's new drug JMHT06 has received approval for clinical trials for acute gouty arthritis [13] Group 5 - Anlian Ruishi has established a joint venture for embodied intelligent robots with a registered capital of 20 million yuan [14] - Kelin Electric's application for a private placement has been accepted by the Shanghai Stock Exchange [15] - Guoyao Modern's subsidiary has received approval for the listing of Agomelatine raw materials, used in antidepressant synthesis [16] Group 6 - Xintiandi's application for the listing of Ferrous Fumarate raw materials has been approved, which is used for treating iron deficiency anemia [17] - ST Weihai, as the leading party, won a bid for a smart agriculture project worth 652 million yuan, accounting for 26.27% of its 2024 audited revenue [18] - Tian Youwei plans to purchase 100% of Krämer Automotive Systems for 1 million euros [19] Group 7 - Guangdong Yuedian A's subsidiary has successfully put into operation the third unit of its Dapu Power Plant project [20] - China Life's total premium exceeded 700 billion yuan as of November 30, 2025 [21] - Shoukai Co. achieved a total signed amount of 15.988 billion yuan in the first 11 months of 2025 [22] Group 8 - Kehua Bio's subsidiary has obtained a medical device registration certificate for an automatic chemiluminescence immunoassay analyzer [23] - Chengyi Pharmaceutical received a drug registration certificate for Torasemide tablets, which have passed the consistency evaluation [24] - Chongqing Construction won a bid for a municipal engineering project worth approximately 1.714 billion yuan [25] Group 9 - Hanjian Heshan signed a procurement contract for pipes worth 388 million yuan [26] - Jiuzhou Pharmaceutical plans to use up to 1 billion yuan of idle raised funds for cash management [27] - Xinwufeng reported an 80.97% year-on-year increase in pig sales in November 2025 [28] Group 10 - Luoniushan reported a 13.57% year-on-year increase in pig sales revenue in November 2025 [29] - Fushilai received a drug registration certificate for Alpha-Lipoic Acid tablets, used for diabetic neuropathy [30] - Dizhe Pharmaceutical presented research data on two innovative drugs at the 67th American Society of Hematology conference [31] - David Medical's subsidiary received two medical device registration certificates for single-use gastric tubes and electronic ureteral endoscope catheters [32]
韩建河山获3.88亿元管材采购合同
Zhi Tong Cai Jing· 2025-12-09 08:13
韩建河山(603616)(603616.SH)发布公告,公司近日收到了某集团有限公司与公司双方签字盖章的管 材采购合同,签约合同价为3.88亿元人民币。本次交易属于招标人通过招标后与中标人签订的管材采购 合同,合同约定的产品与公司现有主营产品一致,属于公司日常经营业务范围。 ...